HCA
66
2
PNC
75
3
ROP
41
-7
FTI
69
5
IR
65
2
CL
56
2
WM
48
-2
BEN
48
2
AZO
38
-8
DLTR
62
-2
MU
68
2
MCK
60
-2
AME
56
-6
PBI
49
3
PGR
52
3
AEE
55
-3
WU
41
2
MAC
62
2
STT
73
2
PNR
56
-3
HCA
66
2
PNC
75
3
ROP
41
-7
FTI
69
5
IR
65
2
CL
56
2
WM
48
-2
BEN
48
2
AZO
38
-8
DLTR
62
-2
MU
68
2
MCK
60
-2
AME
56
-6
PBI
49
3
PGR
52
3
AEE
55
-3
WU
41
2
MAC
62
2
STT
73
2
PNR
56
-3
Financhill
Back

Cornerstone Total Return Fund Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
59

CRF
Cornerstone Total Return Fund

Last Price:
$8.01
Seasonality Move:
3.03%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
59
Cornerstone Total Return Fund (CRF) is a Buy

Is Cornerstone Total Return Fund a Buy, Sell or Hold?

  • The current Cornerstone Total Return Fund [CRF] share price is $7.96. The Score for CRF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CRF Stock Price Chart

What is Cornerstone Total Return Fund's stock price today?

  • The Cornerstone Total Return Fund share price today is $7.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRF is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

CRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 51.36 Buy
Chaikin Money Flow: -426246 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.82 - 8.04) Buy
Bollinger Bands (100): (7.81 - 8.05) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

CRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.98 Sell
20-day SMA: 7.91 Buy
50-day SMA: 7.99 Sell
200-day SMA: 7.62 Buy
8-day EMA: 7.96 Sell
20-day EMA: 7.94 Buy
50-day EMA: 7.94 Buy
200-day EMA: 7.86 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Cornerstone Total Return Fund Earnings Growth & CRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Cornerstone Total Return Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):